Ranked by severity: first, margin fragility — gross margin jumped from 37.15% to 50.70% in a year, but TTM gross margin is only 39.14%, so a revenue deceleration would compress margins quickly and make the $6.03 consensus EPS unreachable, leaving the stock expensive even after a 41% decline. Second, customer and segment concentration — Foundry & Logic ($121.84 million) plus DRAM ($85.00 million) represent roughly 80% of the $258.24 million quarterly total, so a pause in HBM or advanced packaging capex at a handful of AI-driven customers would hit the core business directly. Third, valuation and sentiment risk — at 38.60x EV/EBITDA the stock capitalizes peak-cycle EBITDA, and with upgrades clustered in May-June near the highs and a $110-$200 target range spanning ~82% of the current price, a wave of downgrades could extend the de-rating. Fourth, volatility risk — beta of 1.182 understates reality given a -47.82% max drawdown and 10% single-day moves, meaning position sizing matters as much as the fundamental thesis.

The scenario framework assigns a 50% probability to the base case of $110-$152, a 30% probability to the bull case of $152-$200, and a 20% probability to the bear case of $47-$83. The base case assumes revenue growth decelerates from 31.9% toward the high-teens consistent with consensus $1.654 billion, gross margin settles in the mid-40s rather than the 50.7% peak, and EPS lands between the $4.49 low and $6.03 average estimate, with the stock stabilizing above $83.45 and retesting the $110-$120 supply zone. The bull case requires 50%+ gross margins to hold, forward EPS of $6.03 to materialize, and the multiple to re-rate toward the $152.22 average, with the $200 high target demanding sustained margin expansion and advanced-test share gains. The bear case assumes HBM and advanced packaging orders decelerate, gross margin reverts toward 39%, and the stock retests the $47.33 52-week low with no sell-side floor beneath the $110 low target. The base case is most likely, and its key assumption is that the margin inflection proves durable rather than a one-quarter spike.

The answer depends entirely on which earnings base you trust. On trailing figures the stock is expensive — 82.94x PE, 38.60x EV/EBITDA, 38.92x price-to-cash-flow, and 5.72x sales — but on forward consensus EPS of $6.03 the PE collapses to 20.67x, which is modest for a company with 31.9% revenue growth and 50.7% gross margins. The 62-point gap between trailing and forward PE is the market's implicit bet that the record Q2 profitability is a new baseline rather than a peak-cycle spike. Relative to its own history the stock has already de-rated substantially: the current 5.72x PS and 4.34x price-to-book sit well below the Q2 2026 readings of 39.45x PS and 45.40x PE, and price-to-book is near the middle of its 2.1x-9.2x historical band. The market is therefore paying a fair-to-modestly-undervalued price on forward earnings but a premium on trailing metrics — a dislocation candidate, not yet a confirmed bargain.

The risk/reward is asymmetric but unconfirmed. On the positive side, nine analysts carry a mean rating of 1.8 (buy) with an average target of $152.22, implying roughly 74% upside from $87.53, and even the $110 low target sits 26% above the current price; the forward PE of 20.67x is undemanding for a business that just grew revenue 31.9% YoY at a 50.70% gross margin. On the negative side, the stock fell 41.38% in a month including a -10.19% single session, and the 38.60x EV/EBITDA and 82.94x trailing PE show how much of the thesis rests on forward estimates that require earnings to roughly quadruple. The biggest downside risk is a retest of the $47.33 52-week low, roughly -46% from here, if AI test demand normalizes and gross margin reverts toward 39%. It is a reasonable buy only for growth-oriented investors who stage entries and accept that volatility, ideally adding on confirmation of gross margin above 48% or a reclaim of $110-$120; for conservative or income-focused investors, it is not suitable.

FORM fits a medium-to-long-term growth holding rather than a short-term trade, but only with disciplined position sizing. The company is in an expansion phase — four consecutive quarters of sequential revenue growth from $195.80 million to $258.24 million, 215% earnings growth, and a self-funded balance sheet with 0.0433 debt-to-equity, a 4.50 current ratio, and $136.12 million TTM free cash flow — which argues for holding through the cycle rather than trading the noise. However, the beta of 1.182, -47.82% max drawdown, and 10% single-day moves mean short-term traders face severe whipsaw risk, and the absence of any dividend (0% yield) removes the income cushion that would justify patience for conservative holders. Earnings visibility is improving but still hinges on AI capex at a concentrated customer base, so a minimum holding period of 12-24 months is appropriate to let the margin-durability question resolve across two to four quarters. Short-term traders should wait for a reclaim of $110-$120 or a confirmed hold of $83.45 before entering, while long-term investors can stage entries in thirds around current levels and add on confirmation.